Tag: Cancer: Ovarian
Surgery, Chemo Best for Elderly With Advanced Ovarian Cancer
Longest survival time for primary debulking surgery, chemotherapy with optimal timeframe
Longer Follow-Up Needed to Evaluate Ovarian CA Screening
Significant reduction in mortality with multimodal screening when prevalent cases excluded
Pre-Op Blood Tests May Predict Post-Op Morbidity in Ovarian CA
Pre-op thrombocytosis, leukocytosis tied to post-op morbidity; increased mortality for patients with both
Vitiligo Can Mask Symptoms of Acanthosis Nigricans
In this case report, masking could have resulted in delay of identification of ovarian cancer
Adjuvant Hormone Tx Ups Survival in Epithelial Ovarian CA
Significant improvement in overall, relapse-free survival for women receiving five-years of AHT
Eudaimonic Well-Being Tied to Ovarian Tumor Neuroeffector
Positive affect, psychological distress not associated with tumor norepinephrine
Nonselective Beta-Blocker Use Ups Survival in Ovarian Cancers
Longer median overall survival for patients receiving any beta-blocker versus nonusers
RAD51 Mutations Confer Moderate Risk of Ovarian Cancer
RAD51C and RAD51D deleterious mutations linked to increased risk of epithelial ovarian cancer
Multigene Test IDs More at Risk for Hereditary Breast/Ovarian CA
Testing for mutations other than BRCA1/2 in HBOC may change clinical management for women, families
~30 Percent With Epithelial Ovarian CA Survive Long Term
Predictors for long-term survival include younger age, early stage, low grade, non-serous histology
